Phillip Storm, MD, Named a Healthcare Hero
Published on
The National Liberty Museum hosted the first Healthcare Heroes Awards sponsored by TEVA Pharmaceuticals on Nov. 19, 2018, with the presentation of four awards. The international awards program recognized inspirational heroes in healthcare research and treatment whose accomplishments have profoundly benefitted their patients, their field and the global community. The Healthcare Heroes Awards are dedicated to the life and legacy of Richard S. Egosi, former Teva Group Executive Vice President and Chief Legal Officer who recently lost his battle with cancer.
The Healthcare Hero in the field of Cancer, awarded to a researcher or practitioner for pioneering work that has propelled forward cancer research and patient health and treatment, was awarded to Phillip “Jay” Storm, MD, Chief of the Division of Neurosurgery and Co-director of the Center for Data Driven Discovery in Biomedicine at Children’s Hospital of Philadelphia (CHOP) for his transformative work in pediatric brain tumor research and care.
“We are honored to support the Teva Pharmaceuticals Healthcare Heroes Awards program, which showcases qualities emblematic of the heroes celebrated by the National Liberty Museum. The four honorees not only have demonstrated innovation, entrepreneurial brilliance, and impact in healthcare research and/or treatment; but, have also earned respect and admiration of their professional colleagues, patients and the greater community,” said Brendan O’Grady, EVP and Head of North America Commercial, Teva.
“The Teva Pharmaceuticals Healthcare Heroes Awards honor outstanding individuals who have exhibited the virtues of liberty that are core to the National Liberty Museum’s mission: integrity, empathy, curiosity, creativity, passion, perseverance, innovation and courage,” said Gwen Borowsky, CEO of the National Liberty Museum.
Working together to discover cures for childhood brain tumors
In 2009, alongside fellow surgeons, oncologists, pathologists and other academics, Storm partnered with patients, foundations and their families to launch a new “open science” collaborative at CHOP called the Children’s Brain Tumor Tissue Consortium (CBTTC), a collaborative, multi-institutional research program dedicated to the study and treatments of childhood brain tumors.
Expanding research efforts beyond surgery, the CBTTC has developed a network of informatics and “big data” applications which allow researchers from across the world to work together to discover cures. Over the past eight years, the CBTTC has created the world largest pediatric brain tumor atlas, which is free and available to access by researchers all over the world.
Building on the model of the CBTTC, Storm looked for ways to bridge discovery across adult and pediatric cancer care and research, and in 2017 led the launch of the Philadelphia Coalition for a Cure (PC4C), a first-in-kind cooperative clinical diagnostics and research initiative focused on assessing and developing leading-edge technologies and diagnostic platforms with the goal of streamlining research and precision medicine efforts.
Richard, S. Egosi, to whom the Healthcare Heroes Awards are dedicated, had a 21-year career with Teva Pharmaceuticals as the Executive Vice President, Chief Legal Officer, and Company Secretary. Additionally, Mr. Egosi was a member of the Teva Executive Committee and oversaw the legal, compliance, intellectual property, and public policy functions for Teva. The international award was developed to honor Mr. Egosi in a manner that reflects and pays tribute to his life, leadership and legacy.
A longer version of this article originally appeared on the Data Driven Discovery in Biomedicine website: "D3B Co-Director Jay Storm Receives Healthcare Heroes Award"
